GLIMEPIRIDE RELATED COMPOUND C (20 MG) (GLIMEPIRIDE URETHANE);GliMepiride Related CoMpound C;GliMepiride urethane;GliMepiride EP IMpurity C;N-[[4-[2-[[(3-Ethyl-2,5-dihydro-4-Methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]aMino]ethyl]phenyl]sulfonyl]carbaMic Acid Methyl Ester;Methyl ((4-(2-(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenyl)sulfonyl)carbamate;Glimepiride Related Compound C (20 mg) (glimepiride urethane, or methyl ((4-(2-(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenyl)sulfonyl)carbamate);[4- [2-[3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido]ethyl]phenyl]sulfonyl]methyl carbamate
N-[[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]carbamic Acid Methyl Ester, is an impurity of Glimepiride (G410150), which is a medium- to long-acting sulfonylurea antidiabetic drug.
